|
|
THE FOURTH INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
Getting to a High Integrity Future Sustainably
|
May 17 - 19, 2010
InterContinental Berlin
Berlin, Germany
|
|
IFPMA ANNOUNCES CODE WORKSHOP: HANDS ON COMPLIANCE TRAINING IMMEDIATELY FOLLOWING INTERNATIONAL PARMA CONGRESS
|
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) (www.ifpma.org) is offering an IFPMA Code Workshop: Hands-on Compliance Training on 19 & 20 May 2010 immediately following The International Pharma Congress at the InterContinental Berlin in Berlin, Germany.
Registration Now Open to All
Registration for the IFPMA Workshop was limited to company compliance professionals and in-house counsel through Friday, April 16, 2010. Registration is now open to all on a first come, first serve basis.
Click here for an overview and agenda of the IFPMA Workshop.
Click here to register for the IFPMA Workshop.
Click here to register for a special discounted package registration for the International Pharma Congress and the IFPMA Code Workshop.
|
|
FEATURING THE FOLLOWING
|
|
PRECONFERENCE SESSIONS
|
|
Precon I: International Compliance Program Basics
Precon II: FCPA, Antibribery and Anticorruption in Asia and Middle East
Precon III: Recent Developments in Antitrust Enforcement and Impact on IP Protection and Life Cycle Management Strategies
|
|
|
TRACK SESSIONS
|
|
Track I: Compliance Effectiveness and Adequate Procedures
Track II: Transparency
Track II: International Clinical Trails
Track IV: International Compliance Hot Issues and Case Studies
|
|
|
AND SPECIAL SESSIONS
|
|
Setting the Scene: International Compliance Professional Roundtable
What Patients Want from Pharma
European Healthcare Fraud and Corruption in the Pharmaceutical Sector
EFPIA Code: New Trends and Moving Forward
IFPMA Code Harmonization
Code Awareness Campaign - Examples and Best Practices
The Long Reach of the FCPA
Individual Culpability and Responsibility
The Next Challenge in Global Pharma Compliance: Conflict of Interest, Independence of HCPs, CME and Transparency
Global Compliance Roundtable |
US State Reporting and Aggregate Spend Laws and the Proposed Federal Sunshine Act
The French and Proposed Dutch Transparency Laws
Practical Approaches to Dealing with Global Transparency Requirements
Managing Multi-jurisdictional Investigations, Handling Multiple Regulators and Reaching Global Resolutions
Third-party Due Diligence in the Context of Financial Relationships and Acquisitions/Mergers
Advanced Cultural Passport - Managing Cultural Differences in a Consolidation and Harmonization Environment
|
|
|
CONGRESS CO CHAIRS
|
Dominique Laymand, Esq.
Executive Director Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France |
Roeland van Aelst
Executive Director International, WW Office Health Care Compliance & Privacy (EMEA, Canada, Lat-Am, Asia-Pac), Johnson & Johnson, Brussels, Belgium |
Paul B. Woods, BPharm, MA, MRPharmS
Global Compliance Policy Director, AstraZeneca, Co chair, EFPIA Informed Patient Task Force, Macclesfield, Cheshire, UK
|
|
|
|
KEYNOTE SPEAKERS
|
Richard Bergstrom, MscPharm
Managing Director, Swedish Association of the Pharmaceutical Industry, Chairman, EFPIA Code Steering Committee, Chairman, IFPMA Code Compliance Network, Stockholm, Sweden |
Elena Kamilarova
DG Competition, European Commission, Brussels, Belgium |
David O'Shaughnessy
Vice President, Global Compliance Strategy, AstraZeneca, London, England
|
Philip Schneider, MS
Associate Dean, University of Arizona, Co chair, IFPMA/FIP Working Group on Ethical Interactions between Pharmacists and Pharmaceutical Companies, Phoenix, AZ, USA |
Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, UK |
Hildrun Sundseth
Member of the Board, European Institute of Women's Health, Former Head of EU Policy, European Cancer Patient Coalition, Brussels, Belgium
|
Matthijs M. van Blokland, Esq.
Legal Counsel, Nefarma, Amsterdam, Holland |
Paul Vincke
President, European Healthcare Fraud and Corruption Network, Brussels, Belgium
|
|
|
|
LEADING COMPANY COMPLIANCE PROFESSIONALS AND LEGAL COUNSEL
|
Ann Beasley Bacon, Esq.
Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland |
Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc., Mannheim, Germany |
Erik Eglite, DPM, JD
Vice President, Chief Compliance Officer and Corporate Counsel, Lundbeck Inc., Former Vice President, Chief Compliance Officer and Corporate Counsel, Ovation Pharmaceuticals, Inc. Deerfield, IL, USA
|
Michael Fadus
Regional Compliance Director, Eastern Europe / Middle East & Africa, Merck & Co., Inc., Lucerne, Switzerland |
Stephen F. Mohr, Esq.
Global Compliance Officer, AstraZeneca, London, UK |
Arthur Muratyan, Esq.
Vice President, Head of Legal Corporate and Global Compliance Officer, Sanofi Aventis, Paris, France
|
Jeffrey Rosenbaum
Global Head, Ethics and Compliance, Novartis Oncology, Florham Park, NJ, USA |
Sue Seferian, Esq.
Health Care Compliance Officer, Johnson & Johnson Pharmaceuticals, Titusville, NJ, USA |
Angela Staunton
Bayer Healthcare Pharmaceuticals Inc., Berlin, Germany
|
Robert M. Trotta, II
Executive Director, Compliance and Ethics, Bristol-Myers Squibb, Princeton, NJ, USA |
Willy Vanbuggenhout, JD, MBA
Chief Compliance Officer, Johnson & Johnson, Brussels, Belgium
|
|
|
|
A GLOBAL COMPLIANCE ROUNDTABLE FEATURING
|
Asia Overview:
Yuet-Ming Tham, Esq.
Partner, DLA Piper, Former Regional Compliance Director, Legal Division, Corporate Compliance, Pfizer, Inc., Hong Kong |
Latin and South America Overview:
Juan Francisco Millan, MD
Executive Director, CETIFARMA (Pharma Industry Association), Mexico |
Middle East/Africa Overview:
Gabor Danielfy
Senior Director, Health Care Compliance and Privacy EMEA, Johnson & Johnson, Issy-les-Moulineaux, France
|
|
|
|
PROMINENT COMPLIANCE CONSULTANTS AND LEGAL ADVISORS
|
Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France |
Marc Bauer, Esq.
Senior Associate, Hogan Lovells, Munich Germany |
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, Department of Justice, Washington, DC, USA
|
Jennifer Colapietro
Director, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers, Florham Park, NJ |
Guillaume De Durat
Partner, Amynos Consulting, Former Deputy General Secretary, Leem, Paris, France |
Gary DiBianco, Esq.
Partner, Skadden Arps LLP, London, UK
|
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, London, UK |
Catriona Hatton, Esq.
Managing Partner, Brussels Office, Hogan Lovells, Brussels, Belgium |
Jonathon L. Kellerman
Partner, Pharmaceutical and Life Sciences Practice, PricewaterhouseCoopers LLP, Philadelphia, PA, USA
|
Maurits J.F. Lugard, MA, JD, LLM
Partner, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium |
Kathleen Meriwether, Esq.
Principal, Fraud Investigation & Dispute Services, Ernst & Young, Philadelphia, PA, USA |
Kristina Nordlander, Esq.
Partner, Sidley Austin LLP, Brussels, Belgium
|
Suzanne Rab, Esq.
Counsel, Hogan Lovells, London, UK |
Thilo Räpple, Dr. jur.
Partner, Baker & McKenzie, Frankfurt, Germany |
Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PricewaterhouseCoopers LLP, Baltimore, MD, USA
|
Michael Roberts, Esq.
Senior Associate, Hogan Lovells, London, UK |
Joerg Schickert, Esq.
Partner, Hogan Lovells, Munich, Germany |
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division, U.S. Department of Justice, Washington, DC
|
Mariusz Witalis
Partner, Fraud Investigations and Dispute Services, Ernst & Young, Warsaw Area, Poland |
Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium
|
|
|
|
|
|
|
SPONSORED BY:
|
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall.
|
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
GOLD
|
|
|
BRONZE
|
|
|
CO SPONSORS
|
|
|
2010 INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE
|
Dominique Laymand, Esq. (Co chair)
Executive Director Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb
Roeland van Aelst (Co chair)
Executive Director International, WW Office Health Care Compliance & Privacy (EMEA, Canada, Lat-Am, Asia-Pac), Johnson & Johnson
Paul B. Woods, BPharm, MA, MRPharmS (Co chair)
Global Compliance Policy Director, AstraZeneca
Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services
Karie Jo Barwind, Esq.
Area Director Business Practices, Western Europe, Abbott Laboratories
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP
Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc.
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca
Michael Fadus
Regional Compliance Director, Eastern Europe / Middle East & Africa, Merck & Co., Inc.
Linda Horton, Esq.
Partner, Hogan Lovells
Jonathon L. Kellerman
Partner, Pharmaceutical and Life Sciences Practice, PricewaterhouseCoopers LLP
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP
Maurits J.F. Lugard, MA, JD, LLM
Partner, Sidley Austin LLP, Former Member of the European Commission's Legal Service
David O'Shaughnessy
Vice President, Global Compliance Strategy, AstraZeneca
Dan Ostergaard
Head of Corporate Integrity & Compliance, Novartis International AG
Maxine Nogard
International Compliance Officer, Wyeth
|
|
|
PAST INTERNATIONAL PHARMA CONGRESSES
|
2007 - Brussels, Belgium
2008 - Paris, France
2009 - Rome, Italy
|
|
|
SAVE THE DATE
|
ELEVENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Transformational Learning - Effective Knowledge Exchange
Sponsored by Pharmaceutical Compliance Forum
October 20 - 22, 2010
JW Marriott
Washington, DC
www.PharmaCongress.com
|
|
|
FOLLOW INTERNATIONAL PHARMA CONGRESS ON
|
|
|
|
|
